Chronobiology: Influence of circadian rhythms on the therapy of severe pain

Journal of Oncology Pharmacy Practice

Volumn 16, Issue 2, 2010, Pages 81-87

  Junker, Uwe ^a   Wirz, Stefan ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Cura Krankenhaus   (Germany)

Author keywords

Chronobiology; Circadian rhythm; Opioid analgesics; Pain therapy; Severe pain

Indexed keywords

BUPRENORPHINE; CODEINE; DIPYRONE; ENDORPHIN; ENKEPHALIN; FENTANYL; HYDROMORPHONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE AGONIST; OPIATE RECEPTOR; TRAMADOL; NARCOTIC ANALGESIC AGENT;

ANALGESIC ACTIVITY; BEDTIME DOSAGE; CANCER PAIN; CHRONIC PAIN; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONSTIPATION; CONTINUOUS INFUSION; DAYTIME SOMNOLENCE; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG ABSORPTION; DRUG EFFICACY; DRUG METABOLISM; DRUG TOLERABILITY; DYSPHAGIA; HUMAN; INSOMNIA; LABOR PAIN; LOW BACK PAIN; MORNING DOSAGE; NOCICEPTION; NONHUMAN; PAIN; PAIN ASSESSMENT; PAIN PARAMETERS; PALLIATIVE THERAPY; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SELF MEDICATION; SLEEP DISORDER; SUSTAINED DRUG RELEASE; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE; ANIMAL; DRUG EFFECT; HOSPITALIZATION; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANALGESICS, OPIOID; ANIMALS; CIRCADIAN RHYTHM; HUMANS; PAIN; PAIN MEASUREMENT; SEVERITY OF ILLNESS INDEX;

EID: 77952780782     PISSN: 10781552     EISSN: None     Source Type: Journal    
DOI: 10.1177/1078155209337665     Document Type: Review

References (35)

1. Lemmer B. Chronopharmakologie. Symposium Chronobiologie, Wien 2005 ; Abstr. p. 8.
2. Hildebrandt G., Moser M., Lehofer M. Chronobiologie and chronomedizin. Stuttgart: Hippokrates Verlag, 1998, pp. 92-93.
3. Auvil-Novak SE The chronobiology, chronopharmacology, and chromotherapeutics of pain. Ann Rev Nurs Res 1999 ; 17: 133-153.
4. Labrecque G., Vanier MC Biological rhythms in pain and in the effects of opioid analgesics. Pharmacol Ther 1995 ; 68: 129-147.
5. Pllmann L. Duality of pain demonstrated by the circadian variation in tooth sensitivity. In: Haus E, Kabat H. eds. Chronobiology 1982-1983. Basel: Karger, 1984, pp. 225-228.
6. Aya AG, Vialles N., Mangin R. et al. Chronobiology of labour pain perception: an observational study. Br J Anaesth 2004 ; 93 (3). 451-453.
7. Bellamy N., Sothern RB, Campbell J. Aspects of diurnal rhythmicity in pain, stiffness, and fatigue in patients with fibromyalgia. J Rheumatol 2004 ; 31 (2). 379-389.
8. Chassard D., Bruguerolle B. Chronobiology and anesthesia. Anesthesiology 2004 ; 100: 413-427.
9. Bruera E., Macmillan K., Kuehn N., Miller MJ Zirkadian distribution of extra doses of narcotic analgesics in patients with cancer pain: a preliminary report. Pain 1992 ; 49: 311-314.
10. Nicholson B., Ross E., Sasaki J., Weil A. Randomized trial comparing polymer-coated extended-release morphine sulphate to controlled release oxycodone HCl in moderate to severe non-malignant pain. Curr Med Res Opin 2006 ; 22: 1503-1514.
11. Morris RW, Lutsch EF Susceptibility to morphine-induced analgesia in mice. Nature 1967 ; 216: 494-495.
12. Bernstein Rill, Crocket RS, Smith RP Diurnal variations in the analgesic effectiveness of morphine in mice. Pharmacy Brioche Behav 1977 ; 6: 621-626.
13. Yoshida M., Ohdo S., Takane H., Tomiyoshi Y., Matsuo A., Yukawa E. et al. Chronopharmacology of analgesic effect and its tolerance induced by morphine in mice. J Pharmacol Exp Ther 2003 ; 305 (3). 1200-1205.
14. Wesche DL, Frederickson RC The role of the pituitary in the diurnal variation in tolerance to painful stimuli and brain enkephalin levels. Life Sci 1981 ; 29: 2199-2205.
15. Lemmer B. Chronopharmakologie; Tagesrhythmen and Arzneimittelwirkung. 3. Auflage. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH, 2004, pp. 70-77.
16. Naber D., Wirz-Justice A., Kafka MS Zirkadian rhythm in rat brain opiate receptor. Neurosci Lett 1981 ; 21: 45-50.
17. Petraglia F., Facchinetti F., Parrini D., Micieli G., De Luca S., Genazzani AR Simultaneous circadian variation of plasma ACTH, β-lipoprotein, β-endorphin and cortisol. Horm Res 1983 ; 17: 147-152.
18. Graves DA, Batenhorst RL, Bennett RL, Wettstein JG, Griffen WO, Wright BD et al. Morphine requirements using patient-controlled analgesia: influence of diurnal variation and morbid obesity. Clin Pharm 1983 ; 2: 49-53.
19. Labrecque G., Lepage-Savary D., Poulin E. Time-dependent variations in morphine-induced analgesia. Annu Rev Chronopharmacol 1988 ; 5: 135-138.
20. Auvil-Novak SE, Novak RD, Smolensky MH, Kavanagh JJ, Kwan JW, Wharton JT Twenty-four hour variation in self-administration of morphine sulfate and hydromorphone by post-surgical gynecologic cancer patients. Annu Rev Chronopharmacol 1988 ; 5: 343-346.
21. Auvil-Novak SE, Novak RD, Smolensky MH, Morris MM, Kwan JW Temporal variation in the self-administration of morphine sulfate via patient-controlled analgesia in postoperative gynecologic cancer patients. Annu Rev Chronopharmacol 1990 ; 7: 253-256.
22. Vanier MC, Labrecque G., Lepage-Savary D. Temporal changes in hydro-morphine analgesia in cancer patients. In Smolensky MH et al. eds. Proceedings of the 5th international conference on biological rhythms and medications. Houston: Pergamon Press, 1992, Abstr. XIII-8.
23. Pan PH, Lee S., Harris L. Chronobiology of subarachnoid fentanyl for labour analgesia. Anesthesiol 2005 ; 103 (3). 595-599.
24. Wilder-Smith CH, Wilder-Smith OH Diurnal patterns of pain in cancer patients during treatment with long-acting opioid analgesics. In Smolensky MH et al. eds. Proceedings of the 5th international conference on biological rhythms and medications. Houston: Pergamon Press, 1992, Abstr. XIII-7.
25. Wilder-Smith CH, Schimke JH, Bettiga A. Circadian pain responses with tramadol, a short-acting opioid and alpha-adrenergic agonist, and morphine in cancer pain. In Smolensky MH et al. eds. Proceedings of the 5th international conference on biological rhythms and medications. Houston: Pergamon Press, 1992.
26. Peat S., Sweet P., Miah Y., Barklamb M., Larsen U. Assessment of analgesia in human chronic pain. Randomized double-blind crossover study of once daily repro-dose morphine versus MST continues. Eur J Clin Pharmacol 1999 ; 55: 577-581.
27. Rauck RL, Bookbinder SA, Bunker TR, Alftine CD, Ghalie R., Negro-Vilar A. et al. The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain. J Opioid Manag 2006 ; 2 (3). 155-166.
28. Rauck RL, Bookbinder SA, Bunker TR, Alftine CD, Gershon S., de Jong E. et al. A randomized open-label study of once-a-day AVINZA versus twice-a-day oxycontin for chronic low back pain: the extension phase of the ACTION trial. J Opioid Manag 2007 ; 3 (1). 35-43.
29. Bruera E., Belzile M., Neumann CM, Ford I., Harsanyi Z., Darke A. Twice-daily versus once-daily morphine sulphate controlled release suppositories for the treatment of cancer pain. Support Care Cancer 1999 ; 7: 280-283.
30. Wagner T., Heinze U. Retardiertes Hydromorphon in der Therapie tageszeitlich unterschiedlicher SchmerzintensitCurrency signten bei Tumorpatienten and multimorbiden Patienten. Poster, Der Deutsche Schmerztag, Frankfurt, 2007.
31. Hanks GW, De Conno F., Cherny N., Hanna M., Kalso E., McQuay HJ et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Brit J Cancer 2001 ; 84: 587-593.
32. Radbruch L., Nauck F. Morphin and andere Opioide in der Tumorschmerztherapie - Die Empfehlungen der EAPC. Schmerz 2002 ; 16: 186-193.
33. Ahmedzai S., Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group. J Pain Sympt Manage 1997 ; 13 (5). 254-261.
34. Pllmann L. Study on the chronobiology of the teeth. Rev Stomatol Chir Maxillofac 1981 ; 82: 201-203.
35. Wirz S., Wittman M., Schenk M., Schroeck A., Schaefer N., Mueller M. et al. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl and transdermal buprenorphine. Eur J Pain 2008, October 30 [Epub ahead of print].